Clinical Trial Detail

NCT ID NCT01206530
Title FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Bevacizumab

Hydroxychloroquine

Age Groups: adult

No variant requirements are available.